Actively Recruiting

Phase 3
All Genders
NCT02423395

Study of Orphenadrine' in the Treatment of Muscle Cramps in Patients With Cirrhosis

Led by Sherief Abd-Elsalam · Updated on 2019-06-07

100

Participants Needed

1

Research Sites

726 weeks

Total Duration

On this page

Sponsors

S

Sherief Abd-Elsalam

Lead Sponsor

T

Tanta University

Collaborating Sponsor

AI-Summary

What this Trial Is About

Muscle cramps are common in patients with liver disease and associated with significantly diminished quality of life. Patients with cirrhosis often experience muscle cramps with varied frequency and severity. The exact mechanisms by which they occur remain unclear, although a number of pathophysiological events unique to liver disease may contribute. Clinical studies have identified alterations in 3 areas: nerve function, energy metabolism, and plasma volume/electrolytes (1) Orphenadrine is an anticholinergic drug with prominent central nervous system (CNS) and peripheral actions used to treat painful muscle spasms and other similar conditions. The combination of anticholinergic effects and CNS penetration make orphenadrine useful for pain of all etiologies, including from: radiculopathy, muscles, and headaches. \[3,4\]

CONDITIONS

Official Title

Study of Orphenadrine' in the Treatment of Muscle Cramps in Patients With Cirrhosis

Who Can Participate

All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Cirrhosis
  • Muscle cramps occurring 3 or more times per week
Not Eligible

You will not qualify if you...

  • Allergy to orphenadrine
  • Renal impairment
  • Pregnant or breastfeeding women
  • Peripheral vascular disease
  • Peripheral neuropathy
  • Taking calcium channel blockers, conjugated estrogens, or naproxen
  • Glaucoma
  • Prostatic enlargement

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Tanta university hospital

Tanta, Egypt

Actively Recruiting

Loading map...

Research Team

S

Sherief M Abd-Elsalam, lecturer

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here